Sibeprenlimab (VIS649) is a humanized IgA nephropat (IgAN)[1].
[1]. Mohit Mathur, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healt Volunteers. Kidney Int Rep. 2022 Feb 8;7(5):993-1003.
















